Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Stock Performance
The firm has a market cap of C$21.54 million and a P/E ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The stock’s 50-day moving average is C$2.00 and its 200 day moving average is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- Overbought Stocks Explained: Should You Trade Them?
- Market Momentum: 3 Stocks Poised for Major Breakouts
- What Investors Need to Know About Upcoming IPOs
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- How to Evaluate a Stock Before Buying
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
